About: Ghandi Laurent Damaj

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Ghandi Laurent Damaj Goto Sponge NotDistinct Permalink

An Entity of Type : foaf:Person, within Data Space : data.idref.fr associated with source document(s)

Attributes	Values
type	Person
sameAs	Damaj, Ghandi Laurent (1965-... ; enseignant hospitalo-universitaire en hématologie) Damaj, Ghandi Laurent (1965-... ; enseignant hospitalo-universitaire en hématologie)
alternative label	Damaj, Ghandi
Life Event	http://www.idref.fr/129296511/birth
preferred label	Damaj, Ghandi Laurent (1965-... ; enseignant hospitalo-universitaire en hématologie)
name	Ghandi Laurent Damaj
dbpedia-owl:citizenship	http://sws.geonames.org/3017382/
Language	http://lexvo.org/id/iso639-3/fra
Given name	Ghandi Laurent
familyName	Damaj
has biographical i...tion (Deprecated)	Docteur en médecine, praticien hospitalier en Hématologie, actif en 2008 Professeur des Universités, praticien hospitalier, hématologue et membre de l'unité de recherche \"Génomique du cancer et du cerveau' - GENOMICS - à l'Université de Caen Normandie, UFR Santé (en 2023)
gender	male
ORCID iD	0000-0002-4689-3882
org:hasMembership	http://www.idref.fr/129296511/affiliation/2 http://www.idref.fr/129296511/affiliation/1
org:memberOf	Université de Caen Normandie Cancer and Brain Genomics (Rouen ; 2022-....)
is sameAs of	Damaj, Ghandi Laurent (1965-... ; enseignant hospitalo-universitaire en hématologie) Damaj, Ghandi Laurent (1965-... ; enseignant hospitalo-universitaire en hématologie) Damaj, Ghandi Laurent (1965-... ; enseignant hospitalo-universitaire en hématologie) Damaj, Ghandi Laurent (1965-... ; enseignant hospitalo-universitaire en hématologie)
is Thesis advisor of	http://www.sudoc.fr/157050165/id http://www.sudoc.fr/12926346X/id http://www.sudoc.fr/19182741X/id http://www.sudoc.fr/229619746/id http://www.sudoc.fr/26988789X/id http://www.sudoc.fr/243353537/id Mastocytose systémique associée au syndrome myélodysplasique, étude rétrospective du centre de référence nationale des mastocytoses http://www.sudoc.fr/232797501/id http://www.sudoc.fr/24218202X/id Intérêt d’une prophylaxie par Méthotrexate intra-veineux à dose intermédiaire dans le lymphome B diffus à grandes cellules à haut risque de rechute neuroméningée ? http://www.sudoc.fr/26781853X/id Impact thérapeutique de la midostaurin dans la prise en charge des mastocytoses systémiques avancées http://www.sudoc.fr/243255780/id Bendamustine-Etoposide-Cytarabine-Melphalan (BeEAM) versus Carmustine-Etoposide-Cytarabine-Melphalan (BEAM) chez les patients atteints de lymphome à cellules du manteau traités par autogreffe en première ligne, étude comparative rétrospective multicentrique des centres du Lymphoma Study Association (LYSA) http://www.sudoc.fr/24219351X/id
is Praeses of	http://www.sudoc.fr/268233349/id
is Author of	Low dose Rituximab for pre-emptive treatment of Epstein Barr virus reactivation after allogenic hematopoietic stem cell transplantation Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells Lymphoma occurring in patients over 90 years of age: characteristics, outcomes, and prognostic factors. A retrospective analysis of 234 cases from the LYSA. A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the “REal world dAta in LYmphoma and survival in adults” (REALYSA) cohort Impact of azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes: a study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies. Reduced-dose WBRT as consolidation treatment for patients with primary CNS lymphoma: an LOC network study How to perform leukapheresis for procurement of the staring material used for commercial CAR T-cell manufacturing: A consensus from experts convened by the SFGM-TC 18 F-Fludarabine PET for Lymphoma Imaging: First-in-Humans Study on DLBCL and CLL Patients [Evaluation of management disparity in patients with chronic lymphocytic leukemia in France] Cell-of-Origin (COO) Classification, BCL2 and MYC Expression Associated Outcome in Younger Patients Treated By RCHOP Front-Line Therapy Versus Intensive Regimen Followed By Autologous Transplant for De Novo Advanced Diffuse Large B Cell Lymphoma (DLBCL) : Results of the French Prospective Multicenter Randomized Trial Goelams-075 Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS Study Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party Harmonisation of full blood count reports, recommendations of the French-speaking cellular haematology group (GFHC) Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study. Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets PTPN11 mutations in canine and human disseminated histiocytic sarcoma Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides longer disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from the LyMA prospective trial Decreased tryptophan and increased kynurenine levels in mastocytosis associated with digestive symptoms. http://hub.abes.fr/libbey/periodical/hematologie/2019/volume_25/issue_3/CE05BF6265A74A50E053120B220A94A5/w Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party T-cell defect in Diffuse Large B-cell Lymphomas involves expansion of myeloid derived suppressor cells expressing IL-10, PD-L1 and S100A12 Increased frequencies of circulating and tumor-resident Vδ1 T cells in patients with diffuse large B-cell lymphoma Molecular Characterisation of Diffuse Large B Cell Lymphoma in Patients of 80 Years Old or More: Clinical Relevance in a Multicentric Randomized Phase III Study of the Lysa (SENIOR Study) Correction to: Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma Bendamustine-EAM versus R-BEAM after high-dose cytarabine-based induction in newly diagnosed patients with mantle cell lymphoma, a LYSA retrospective study Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma Results from a prospective, open-label, phase II trial of bendamustine in refractory or relapsed T-cell lymphomas: the BENTLY trial. Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study Combining baseline TMTV and gene profiling for a better risk stratification in diffuse large B cell lymphoma Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers French National Retrospective Cohort of Hairy-Cell Leukemias: Risk of Second Malignancies after 10 Years of Follow-up Obinutuzumab versus Rituximab in young patients with advanced DLBCL, a PET-guided and randomized phase 3 study by LYSA Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis CD19 CAR T-Cell Therapy in Patients with Relapse/Refractory DLBCL: Retrospective Analysis of the Eligibility Criteria Deep-Learning Assessed Muscular Hypodensity Independently Predicts Mortality in DLBCL Patients Younger Than 60 Years Multi-drug resistance mediated by P-glycoprotein overexpression is not correlated with ZAP-70/CD38 expression in B-cell chronic lymphocytic leukemia Intravenous high-dose methotrexate based systemic therapy in the treatment of isolated primary vitreoretinal lymphoma: an LOC network study Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life-experience of the French network https://hal.archives-ouvertes.fr/hal-01726196#id The negative influence of baseline cell-free DNA on long-term survival in DLBCL depends on frontline treatment intensity Nonclassical Monocytes Are Prone to Migrate Into Tumor in Diffuse Large B-Cell Lymphoma Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up A randomized phase 3 trial of auto vs. allo transplantation as part of first-line therapy in poor-risk peripheral T-NHL R-CHOP 14 with or without radiotherapy in non-bulky limited-stage diffuse large B-cell lymphoma (DLBCL) New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genes Does PET Reconstruction Method Affect Deauville Score in Lymphoma Patients? Relocalization of KIT D816V to Cell Surface After Dasatinib Treatment: Potential Clinical Implications https://serval.unil.ch/notice/serval:BIB_176EB32E5BC5#id Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA group Assessment of alteration in liver 18F–FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or Older Gastrointestinal manifestations in mastocytosis: A study of 83 patients. SRSF2-p95 hotspot mutation is highly associated with advanced forms of mastocytosis and mutations in epigenetic regulator genes Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma. Management and outcome of primary CNS lymphoma in the modern era Éligibilité des patients aux cellules CAR-T : avis d’experts proposé par la SFGM-TC Prognostic value of high-sensitivity measurable residual disease assessment after front-line chemoimmunotherapy in chronic lymphocytic leukemia https://orbi.uliege.be/handle/2268/288996#id

Faceted Search & Find service v1.13.91 as of Aug 16 2018

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software